Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00221572
First received: September 12, 2005
Last updated: January 29, 2013
Last verified: January 2013
  Purpose

Measurement of bone density of Cystic Fibrosis patients with two techniques and correlation to serum bone parameters, use of steroids, lung function and nutritional status.


Condition Intervention
Cystic Fibrosis
Procedure: Determination of bot density of Cystic Fibrosis patients

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Estimated Enrollment: 100
Study Start Date: July 2005
Estimated Study Completion Date: July 2013
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Determination of bot density of Cystic Fibrosis patients
    Determination of bot density of Cystic Fibrosis patients.
Detailed Description:

Measurement of bone density of Cystic Fibrosis patients with two techniques and correlation to serum bone parameters, use of steroids, lung function and nutritional status.

  Eligibility

Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with Cystic Fibrosis

Criteria

Inclusion Criteria:

  • Patients with Cystic Fibrosis

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00221572

Contacts
Contact: Eddy Robberecht, MD, PhD + 32 9 332.35.89 eddy.robberecht@UGent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: Stephanie Van Biervliet, MD    + 32 9 332.55.14    stephanie.vanbiervliet@UGent.be   
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Stephanie Van Biervliet, MD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00221572     History of Changes
Other Study ID Numbers: 2005/149
Study First Received: September 12, 2005
Last Updated: January 29, 2013
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Cystic Fibrosis
Fibrosis
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Lung Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 30, 2014